| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.19 | 0.003 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |